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Abstract
Evolutionary forces that shape regulatory networks remain poorly understood. In mammals, the Rb pathway is a classic
example of species-specific gene regulation, as a germline mutation in one Rb allele promotes retinoblastoma in humans,
but not in mice. Here we show that p53 transactivates the Retinoblastoma-like 2 (Rbl2) gene to produce p130 in murine, but
not human, cells. We found intronic fuzzy tandem repeats containing perfect p53 response elements to be important for
this regulation. We next identified two other murine genes regulated by p53 via fuzzy tandem repeats: Ncoa1 and Klhl26.
The repeats are poorly conserved in evolution, and the p53-dependent regulation of the murine genes is lost in humans.
Our results indicate a role for the rapid evolution of tandem repeats in shaping differences in p53 regulatory networks
between mammalian species.
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Introduction
Retinoblastoma is the most common pediatric intraocular
tumor, that may arise in an unilateral or bilateral form. In human
bilateral retinoblastoma, a germline mutation in one RB1 allele is
typically observed, and the second allele undergoes somatic
mutation, in agreement with Knudson’s «two-hit hypothesis» for
inherited cancer syndromes [1]. This defined RB as the
prototypical tumor suppressor gene, and prompted several groups
to develop Rb mutant mice. However, Rb
+/2 mice were not found
to develop retinoblastomas, but rather pituitary and thyroid
tumors [2–4]. Retinoblastomas were observed in mutant mice
lacking both Rb and the Rb-like protein p107, or both Rb and the
Rb-like protein p130 [5–8]. Additionnal studies suggested that Rb
loss in the mouse retina does not lead to retinoblastoma due to a
compensatory upregulation of p107 and a partially redundant
expression of Rb and p130 [9–12].
Inactivation of the p53 pathway plays an important role in the
development of murine and human retinoblastomas [13,14]. We
were intrigued by reports showing that p107-deficient mice with
Rb deletion in the developing retina (Chx10Cre; Rb
lox/2; p107
2/2)
develop non invasive retinoblastomas with low penetrance,
whereas similar mice with an additional retina-specific loss of
p53 (Chx10Cre; Rb
lox/2; p107
2/2; p53
Lox/2), or with decreased
p107/p130 levels (Chx10Cre; Rb
lox/lox; p107
+/2; p130
2/2), develop
aggressive and invasive bilateral retinoblastomas [12,13]. This led
us to investigate whether p130 levels might be regulated by p53 in
mice. Surprisingly, the results we obtained revealed common
features for a subset of p53 target genes that are differentially
regulated between mammalian species. We identified three genes
(Rbl2/p130, Ncoa1 and Klhl26) that are regulated in murine cells via
clustered p53 response elements located within imperfect tandem
repeats (often called Fuzzy Tandem Repeats or FTRs). Because
the DNA sequence of FTRs is poorly conserved in evolution, the
p53-dependent regulation of these genes is not observed in human
cells, and only partially conserved in rat cells. These results provide
insights into the evolution of p53 regulatory networks, which may
help to understand species-specific differences in tumorigenesis.
Results
Murine Rbl2/p130 is a p53 target gene
Consistent with the hypothesis that murine p130 could be
regulated by p53, we observed an increase in p130 mRNA levels
in response to doxorubicin in wild-type, but not p53
2/2 mouse
embryonic fibroblasts (MEFs) (Figure 1A). A similar observation
was obtained in vivo, in tissues from irradiated mice (Figure S1).
Importantly, the stress-dependent increase in p130 mRNA levels
led to an increase in p130 protein levels in WT MEFs (Figure 1B).
We also found an increase in p130 mRNA levels in WT cells
treated with Nutlin, the specific inhibitor of MDM2-p53
interaction [15], further suggesting that the stress-dependent
induction of p130 results from an increased p53 activity
(Figure 1C).
We next used an in silico approach to search for potential p53
binding sites in the murine Rbl2 gene. The consensus sequence for
a p53 response element (p53 RE) was first defined as 2 copies of
the 10-base pair motif RRRCWWGYYY separated by 0–13 base
pairs (where R=G/A, W=A/T and Y=C/T) [16]. More
PLoS Genetics | www.plosgenetics.org 1 June 2012 | Volume 8 | Issue 6 | e1002731recently, genome-wide ChIP-on-chip experiments allowed to
further refine the consensus sequence (reviewed in [17,18]). To
perfom an unbiased search for p53 putative binding sites, we used
a positional frequency matrix (PFM) recently generated by a
genome-wide ChIP-on-chip experiment in human cells [19],
modified to take into account varying spacer lengths (Figure S2
and Methods). An analysis of sequences from 6 kb upstream to
2.5 kb downstream of the p130 mRNA transcription start site
(TSS) suggested one putative p53 RE 2.5 kb upstream of the TSS
but more strikingly, a distinctive 117 bp-long cluster of putative
p53 REs containing 7 p53 binding half-sites, 6 of which perfectly
match the canonical RRRCWWGYYY motif (Figure 1D and
Table S1). When the sequences upstream of the TSS were cloned
before a luciferase reporter gene, little p53-dependent induction
could be measured, whereas a strong p53-dependent induction
was found for sequences downstream of the TSS, and the deletion
of clustered p53 REs strongly reduced this induction (Figure 1E).
In addition, the cluster of p53 REs alone, when cloned before a
luciferase reporter gene, ensured a strong p53-dependent induc-
tion (Figure S3). Chromatin immunoprecipitation experiments in
stressed WT and p53
2/2 cells then indicated significant binding of
p53 to this cluster in vivo (Figure 1F). Altogether, the results show
that p53 transactivates murine Rbl2/p130, and that a cluster of
p53 REs in intron 1 is important for this regulation.
The p53 REs in murine Rbl2 are within fuzzy tandem
repeats
The cluster of p53 REs in the murine Rbl2 gene has several
unusual features: 1) a clustering of p53 binding half-sites has already
been described for a few p53 target genes, but the proposed rule for
such clustering is that two p53 binding half-sites match the
consensus RRRCWWGYYY sequence almost perfectly, and
additionnal half-sites have more degenerated sequences [20]. In
themurine Rbl2 gene,6 outof7 p53 half-sitesareperfect matchesto
the consensus, thus exceeding by far the proposed criteria for
clustered p53 binding half-sites; 2) transactivation was shown to
occur through p53 binding to repeated sequences such as retroviral
elements for a fraction of p53 target genes [21,22], or to an unusual
microsatellite repeat (TGYCC)n for the target gene PIG3 [23]. A
duplication most likely participated in the creation of the cluster in
murine Rbl2, as evidenced by the sequence similarities between its
two larger spacers (Figure 1D). However the cluster, as a whole,
does not correspond to any previously described repeated sequence.
To better understand the structure of the cluster, we used mreps,a
software designed to detect repeats, even if they are «fuzzy», i.e. if
they contain mismatches [24]. Strikingly, mreps detected fuzzy
tandem repeats encompassing the entire cluster of p53 REs in
murine Rbl2 (Figure 1G and Figure S4).
The p53 putative binding sites are mutated in human
Rbl2
In human cells, several reports indicated that p130 is involved in
the p53–p21 damage response leading to cellular senescence, but
that p53 does not transactivate Rbl2/p130 [25,26]. However, the
classical assumption that important regulatory networks are
evolutionnary conserved is now being challenged, particularly
for trancription factors Oct4 and Nanog [27], but also for p53
[21,22,28]. Consistent with previous reports, we observed that,
unlike the well-known p53 target Cdkn1a/p21, Rbl2/p130 is not
induced in normal human fibroblasts after treatment with
doxorubicin (Figure 1H) or Nutlin (not shown). The apparent
difference in Rbl2 regulation between murine and human cells led
us to analyze the nucleotide sequence of the human Rbl2 gene. No
cluster of putative p53 RE was found in the intron 1 of human
Rbl2 when using the same PFM-based criteria as for the murine
locus, and most p53 putative binding half-sites were degenerated
in the region homologous to the clustered p53 REs in the murine
gene (Figure 1I and Table S1). Accordingly, mreps did not detect
fuzzy tandem repeats in the intron 1 of human Rbl2. Thus, this
intronic Rbl2 region is poorly conserved between the murine and
human genomes.
BLAST with the Rbl2 p53 RE cluster reveals another
murine-specific p53 target
We performed a BLAST (basic local alignment search tool) over
the mouse genome with the murine Rbl2 p53 RE cluster to
determine if similar cluster(s) could be involved in the regulation of
other p53 target gene(s). A gene was considered a candidate p53
target if stress-induced in WT but not p53
2/2 MEFs (with an
induction at least 2-fold in WT cells), and if containing a cluster of
p53 binding half-sites less than 10 kb upstream, or less than 5 kb
downstream, of the TSS. Only one candidate gene was found to
fulfill these criteria: Ncoa1 (also known as SRC1), with a cluster of
p53 putative half-sites 3.4 kb upstream of the TSS (Figure 2A, 2B
and Figure S5). Further sequence analysis of this cluster with the
p53 PFM and Consite suggested 5 candidate p53 REs (Table S2).
Luciferase assays then demonstrated the importance of this cluster
in the p53-dependent transactivation of Ncoa1 (Figure 2C), and
ChIP showed a modest, but significant p53 binding to this cluster
in vivo (Figure 2D). Like for murine Rbl2, mreps identified fuzzy
tandem repeats within the murine Ncoa1 locus (Figure 2E, Figure
S6), and the cluster was poorly conserved in evolution (Figure 2F).
Accordingly, we did not observe a stress-dependent induction of
Ncoa1 in human fibroblasts (Figure 2G). A BLAST search using the
cluster of p53 half-sites at the Ncoa1 locus did not yield any
additional candidate target gene.
BLAST searches with synthetic clusters reveal a third
gene regulated by p53 in murine but not human cells
We next decided to perform BLAST searches relying on the use
of synthetic clusters of p53 REs. Each synthetic cluster was
Author Summary
TP53, the gene encoding p53, is mutated in more than half
of human cancers. Consequently, p53 is one of the most
studied transcription factors, shown to directly regulate
more than 150 genes. The mouse is a model of choice to
study p53 mutants and cancer. However, differences were
found between tumorigenesis in mice and humans, and
these should be investigated to improve the relevance of
mouse models. The distinct mutational events required to
initiate retinoblastomas in these species constitute a
classic example of such differences. Here we show that
p53 regulates the Retinoblastoma-like 2 (Rbl2) gene,
encoding tumor suppressor p130, in murine but not
human cells. The p53-dependent regulation of murine
Rbl2/p130 relies on clustered p53 response elements,
located within tandem repeats poorly conserved in
evolution. A similar situation was found for two other
genes, also p53 targets in mice but not in humans. Thus,
tandem repeats may shape differences in mammalian p53
regulatory networks. By uncovering differences in p53
target gene repertoires between mice and humans, our
findings may help to improve mice as models of human
disease. In addition, the role of tandem repeats in shaping
the target gene repertoires of other mammalian transcrip-
tion factors should be considered.
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PLoS Genetics | www.plosgenetics.org 2 June 2012 | Volume 8 | Issue 6 | e1002731Figure 1. Murine Rbl2/p130 is a p53 target gene. (A) WT and p53
2/2 MEFs were left untreated (Unt) or treated with doxorubicin (Dox) before
RNA extraction and real-time PCR quantification, in 8 independent experiments. Data were normalized to control mRNA levels, then a value of 1 was
assigned to mRNA amounts in unstressed WT cells. (B) MEFs were treated as in (A), then protein extracts were immunoblotted with antibodies to
p130, p53 and Gapdh. (C) MEFs were left untreated (Unt) or treated with Nutlin (Nut) before RNA quantification, in 4 independent experiments. (D)
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had a sequence among the 128 most likely to be bound by p53,
according to a genome-wide ChIP study [19] (Table S3). We
performed 128 BLAST searches using synthetic clusters with the
same criteria as before: a gene with a cluster 10 kb upstream or
5 kb downstream of its TSS, stress-induced at least 2-fold only in
WT MEFs, was considered a candidate p53 transcriptional target.
With this approach, an additional p53 target gene was identified:
Klhl26. In a recent genome-wide ChIP-chip study, Klhl26 was listed
among 573 stress-induced genes bound by p53 in murine ES cells
[29]. However the study focused on genes in the Wnt signalling
pathway, so that neither luciferase assays, nor quantitative RT-
PCR in WT and p53
2/2 cells were performed to test if Klhl26 and
500+ other candidates were indeed bona fide p53 transcriptional
targets [29]. Here we show that Klhl26 is a p53 target gene, and
that the binding of p53 to clustered p53 REs is important for this
regulation (Figure 3A–3D, Figure S5 and Table S4). Again, fuzzy
tandem repeats are detected at the level of the cluster of p53 REs
(Figure 3E, Figure S7), and the cluster is poorly conserved in
evolution (Figure 3F–3G). BLAST searches with the cluster of p53
REs at the Klhl26 locus did not suggest additional candidate target
genes.
Evidence for a partial divergence in the regulation of
Rbl2, Ncoa1, and Klhl26 among rodents
We identified 3 genes that are p53 transcriptional targets in
murine, but not human cells. To evaluate conservation among
rodents, we analyzed the promoters of these 3 genes in the rat
genome. A single putative p53 RE was found at the rat Rbl2 locus
at the same location as the cluster of p53 REs in the mouse gene,
whereas 0 and 2 putative REs were respectively found at the rat
Ncoa1 and Klhl26 loci, in the regions homologous to those
containing clustered p53 REs in the murine genes (Figure 4A).
These analyses indicated a significant divergence in the DNA
sequence between the mouse and rat genomes at the 3 loci, with
possible regulatory consequences. We next analyzed the mRNA
levels for p21, p130, Ncoa1 and Klhl26 in wild-type primary rat
embryonic fibroblasts (REFs), before or after treatment with
doxorubicin or Nutlin. Both drugs led to strong increases in p21
and Klhl26 mRNAs, whereas p130 mRNA levels were barely
increased, and Ncoa1 mRNAs were not increased at all
(Figure 4B). From these results we conclude that the p53-
dependent regulation of Rbl2, Ncoa1 and Klhl26 observed in
murine cells is, at best, only partially conserved in rat cells.
Sequences containing clustered p53 half-sites diverge
rapidly
We performed a Consite analysis of the first 2.5 kb of Rbl2
genomic sequences in 8 additional mammalian species (rabbit,
dog, cattle, horse, elephant, Rhesus monkey, gibbon and chimp):
this provided further evidence that the clustered p53 REs in
murine Rbl2 are poorly conserved in evolution (Figure 5).
Consistent with this, when we searched for sequences containing
clustered p53 half-sites in these 8 species in addition to mouse, rat
and human, we identified a partial conservation between rodent
species, or among primates, but sequences were more divergent
when distant species were compared (Figure S8). Likewise, the
Consite analysis of genomic sequences at the Ncoa1 and Klhl26
loci in 7 mammalian species indicated a divergence in regulation
among mammals (Figure 6), further supported by a search for
sequences containing clustered putative p53 half-sites. At the
Klhl26 locus, a partial conservation was found among rodents or
among primates, with significant divergence between more
distant species (Figure S9). At the Ncoa1 locus, we could not
identify significant conservation even between closely related
species (not shown). These results indicate that tandem repeats
containing p53 response elements evolve rapidly, which may
account for differences between mammalian p53 transcriptional
repertoires.
Discussion
Our analysis of species-specific gene regulation started from the
observation that unlike humans, Rb
+/2 mice do not develop
retinoblastomas [2–4]. Instead, retinoblastomas develop in mice
with a concomitant loss of Rb and the Rb-like protein p107, or a
concomitant loss of Rb and the Rb-like protein p130 [5–8]. Here
we identified Rbl2/p130 as a p53 target gene in mouse, but not
human cells (Figure 1). Thus, like Rbl1/p107 [9–12], Rbl2/p130 is
differentially regulated in mice and humans, which may account
for the different mutational events required to initiate retinoblas-
toma in these species. Indeed, our findings may explain why
aggressive bilateral retinoblastomas develop after a retina-specific
deletion of Rb in mice with decreased p107/p130 levels, or a
retina-specific loss of both Rb and p53 in mice lacking p107, but
not after a retina-specific loss of Rb in mice lacking only p107
[12,13]. Also possibly consistent with our results, Rb loss is
compensated by increased levels of both p107 and p130 in murine
Ras-induced lung tumors, whereas in lung tumors initiated by a
concomitant loss of Rb and p53, p107 levels are increased but
p130 levels are decreased [30,31]. Interestingly, murine lung
tumors initiated by a loss of Rb and p53, and those initiated by the
loss of Rb, p53 and p130, shared highly similar transcriptomes
[31]. Together, these data suggest that the regulation of murine
Rbl2/p130 by p53 may affect tumor initiation or progression.
We were surprised to find that the p53-dependent regulation of
murine Rbl2/p130 relies on a cluster of p53 response elements
within rapidly evolving Fuzzy Tandem Repeats (FTRs). This led
us to identify two other murine p53 target genes regulated via
Putative p53 REs, identified using Consite and a positional frequency matrix (Methods), were plotted along the Rbl2/p130 locus as lollipops, with
greytones according to scores (Table S1). Numbers are relative to the transcription start site (TSS). Black box: exon 1. Below, the cluster sequence is
shown, with p53 putative binding half-sites in bold (putative binding sites have 0–3 mismatches with the consensus; matches in capital letters and
mismatches in lowercase; perfect half-sites are boxed). (E) The 6 kb upstream the TSS were cloned before a luciferase reporter gene, and the plasmid
was transfected in p53
2/2 MEFs alone (I), or with an expression vector for WT p53 (I+p53WT) or mutant p53 (I+p53R270H) to measure luciferase.
Likewise, luciferase was measured with plasmids containing 2.5 kb of sequences downstream the TSS with (II) or without (III) the clustered p53 REs.
Results, from 3 independent experiments, were normalized to control renilla luciferase, then a value of 1 was assigned to luciferase in cells transfected
with reporter plasmids alone. (F) ChIP assay was performed in doxorubicin-treated MEFs, with an antibody against p53, or rabbit IgG as a control.
Immunoprecipitates were quantified using real-time PCR and normalized to input DNA on an irrelevant region, in 3 independent experiments. (G)
Integrated results of the cluster sequence analysis with mreps. Numbers are relative to the TSS. (H) Human lung fibroblasts were treated and mRNAs
were quantified as in (A), in 3 independent experiments. Similar results were obtained with foreskin fibroblasts. (I) Putative p53 response elements
were searched for and plotted along the human Rbl2/p130 locus as in (D). The region homologous to the murine clustered p53 REs is below, with
putative half-sites as before (those with a single mismatch are underlined). The parentheses indicate a nonamer that might be a putative half-site
with a deletion within the core CWWG motif (the minus sign indicates the deletion), a situation observed in about 5% of p53 binding half-sites [41].
doi:10.1371/journal.pgen.1002731.g001
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(Figure 2 and Figure 3). Both genes were found after BLAST
searches over the mouse genome and expression assays in MEFs.
It remains possible that other murine p53 targets regulated via
FTRs escaped our search, because they are not expressed in MEFs
and/or because BLAST was not programmed to detect FTRs.
Although mreps is more capable of detecting FTRs, it detects
repeats of any sequence, and thus cannot be used to search for
Figure 2. Transactivation of murine Ncoa1 by p53 relies on a cluster of p53 half-sites. (A) Sequence of the clustered p53 REs upstream of
the Ncoa1 gene, represented as in Figure 1D. Numbers are relative to the TSS. The parentheses indicate a putative half-site with a rare variant of the
core CWWG motif: evidence that p53 may bind a half-site with a CWWA core was reported [42], but only 2% of the sequences bound by p53 contain a
p53RE with a CWWA core in its second half-site [19]. (B) MEFs were left untreated (Unt) or treated with doxorubicin (Dox) for 24 h, before RNA
extraction and real-time PCR quantification. Results, from 7 experiments, were plotted as in Figure 1A. (C) A 2.5 kb-long fragment containing
sequences upstream of the Ncoa1 TSS (from 23.5 kb to 21 kb) was cloned before a luciferase reporter gene, and transfected in p53
2/2 MEFs alone
(IV), or with an expression vector for WT p53 (IV+p53WT), or mutant p53 (IV+p53R270H), then luciferase activities were measured. Luciferase activities
were determined with the same sequences after deletion of the clustered putative p53 REs (sequences from 23.1 kb to 21 kb; plasmid V). Results,
from 3 independent experiments, were normalized to control renilla luciferase, then plotted as in Figure 1E. (D) ChIP assay was performed in
doxorubicin-treated p53
2/2 and wild-type MEFs, with an antibody against p53 or rabbit IgG as a control. Immunoprecipitates, from 3 independent
experiments, were quantified and plotted as above. (E) Fuzzy tandem repeats within the Ncoa1 cluster. Integrated mreps results are represented as in
Figure 1G. (F) The cluster of p53 REs at the Ncoa1 locus is poorly conserved in evolution. Candidate p53 REs were searched for at the murine and
human Ncoa1loci and plotted as before. (G) Human fibroblasts were left untreated (Unt) or treated with doxorubicin (Dox) for 24 h, before RNA
extraction and real-time PCR quantification. After stress, p21 mRNAs levels increased (Figure 1H), but not Ncoa1 mRNA levels. Results, from 3
independent experiments, were normalized and plotted as before.
doi:10.1371/journal.pgen.1002731.g002
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programs for ab initio detection of repeats are unable to cope with a
high level of sequence divergence between long (.24 nt) repeats
[32]. In other words, fuzzy tandem repeats are difficult to detect
over an entire genome due to their inherent fuzziness. Thus, the
design of improved methods to find additional p53 targets
regulated via fuzzy tandem repeats is an important goal.
Interestingly, within tandem repeats, the number of clustered
p53 REs with high Consite scores appears to correlate with the
amount of p53 bound to the cluster, according to ChIP assays.
Indeed, the cluster at the Klhl26 locus, with 5 high scoring p53
REs, is strongly bound by p53 (Table S4, Figure 3D), whereas the
cluster at the Ncoa1 locus, containing only 1 high scoring p53 RE,
appears weakly or transiently bound (Table S2, Figure 2D), and
the cluster at Rbl2 ranges in between for both criteria (Table S1,
Figure 1F). The identification of a larger number of genes
regulated via p53 RE-containing FTRs would allow to test this
possible correlation further.
Figure 3. p53 transactivates murine Klhl26 via a cluster of p53 half-sites. (A) Sequence of the cluster of p53 half-sites in Klhl26 intron 1,
represented as in Figure 1D. Numbers are relative to the TSS. (B) WT and p53
2/2 MEFs were left untreated (Unt) or treated with doxorubicin (Dox) for
24 h, before RNA extraction and real-time PCR quantification. Results from 3 independent experiments. (C) A 1 kb-long fragment from Klhl26 intron 1
(from +0.1 kb to +1.1 kb) was cloned before a luciferase reporter gene, to test for p53-dependent reporter activity. The reporter plasmid was
transfected in p53
2/2 MEFs alone (VI), together with an expression vector for p53 WT (VI+p53WT) or for mutant p53 (VI+p53R270H) and luciferase
activities were measured. Similarly, luciferase activities were determined with the same sequences after deletion of clustered putative p53 half-sites
(sequences from +0.39 to +0.64 kb were deleted; plasmid VII). Results, from 3 independent experiments, were normalized to control renilla luciferase,
then plotted as in Figure 1E. (D) ChIP assay was performed in doxorubicin-treated p53
2/2 and wild-type MEFs, with an antibody against p53 or rabbit
IgG as a control. Immunoprecipitates, from 3 independent experiments, were quantified and plotted as before. (E) Integrated results of the mreps
DNA sequence analysis, represented as in Figure 1G. (F) The cluster of p53 REs at the Klhl26 locus is poorly conserved in evolution. Candidate p53 REs
were searched for at the murine and human Klhl26 loci and plotted as before. (G) Klhl26 is not induced in response to stress in human fibroblasts.
Human fibroblasts were left untreated (Unt) or treated with doxorubicin (Dox) for 24 h, before RNA extraction and quantification. After stress, p21
mRNAs levels increased (Figure 1H), but not Klhl26 mRNA levels. Results, from 4 independent experiments, were normalized and plotted as before.
doi:10.1371/journal.pgen.1002731.g003
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conserved in evolution, so that the p53-dependent regulation of
the 3 genes appears only partially conserved among rodents, and
does not operate in humans. Two out of the 3 identified genes are
known to be relevant to cancer biology: Rbl2 is frequently lost in a
variety of human cancers and acts as a bona fide tumor suppressor
in mouse models (e.g. [30]) and Ncoa1 belongs to a family of
transcription co-activators often deregulated in human tumors
[33]. Regarding Klhl26, its function is currently unknown, but it
was found mutated in head and neck squamous cell or ovarian
carcinomas [34,35]. Such a poor conservation in the regulation of
genes apparently directly relevant to p53 tumor suppressive
functions may seem surprising. However, it is possible that partial
functional redundancy, or compensatory mechanisms, buffer the
phenotypic consequences of diverging p53 target gene repertoires
among mammals. The evolution of microRNA regulatory
networks among mammalian species might provide such buffering,
as recently suggested for the microRNA miR-125b [36].
Unstable tandem repeats in promoters confer transcriptional
evolvability in yeasts [37], and evidence of similar mechanisms in
other organisms is accumulating [38]. Our data indicate that the
rapid evolution of fuzzy tandem repeats containing p53 REs may
shape differences in p53 transcriptional networks among mam-
mals. Recently, mice ‘‘humanized’’ to carry a human-specific SNP
in the Mdm2 promoter allowed to demonstrate its importance on
tumor onset [39]. The characterization of species-specific p53
target genes might help to define which genes should have their
regulatory sequences humanized, with the aim of improving
mouse models. Importantly, the possible role of fuzzy tandem
repeats in shaping the target gene repertoire of other mammalian
transcription factors deserves further investigation.
Methods
Cells and tissue cell culture reagents
Primary mouse embryonic fibroblasts were isolated from 13.5
day embryos from p53
+/2 intercrosses, and cultured in a 5% CO2
and 3% O2 incubator for a maximum of 5 passages in DMEM
Glutamax (Gibco), completed with 15% FBS (Biowest), 100 mM
2-mercaptoethanol (Millipore), 10 mM Non Essential Amino-Acids
and Penicillin/Streptomycin (Gibco). Human fibroblasts from the
lung (MRC5) or the foreskin (BJ) were purchased from the
Figure 4. A partial divergence in the regulation of Rbl2/p130, Ncoa1, and Klhl26 among rodents. (A) Homologous regions of the Rbl2,
Ncoa1 and Klhl26 loci from mouse and rat were analyzed with Consite, and results were plotted along the map as before. At each rat locus, 0–2
putative p53 REs were found to map at the same position as a cluster of p53 REs at the homologous murine locus region. Their sequence is indicated
below the map. (B) Primary REFs were left untreated (Unt) or treated for 24 h with doxorubicin (Dox) at 0.5 mg/ml, or Nutlin at 10 mM, before RNA
extraction and real-time PCR quantification. Results were normalized to control mRNA levels, then the mean amount of mRNAs in unstressed cells
was assigned a value of 1. Data are from 3 independent experiments.
doi:10.1371/journal.pgen.1002731.g004
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CO2 and 3% O2 regulated incubator in MEM (Gibco), completed
with 10% FBS, 2 mM L-Glutamine (Gibco), 1 mM Pyruvate,
10 mM Non Essential Amino-Acids and Penicillin/Streptomycin.
HCA2 foreskin fibroblasts, originally prepared by O. Pereira, were
grown like BJ cells. Primary rat embryonic fibroblasts, isolated
from 14.5 days WT embryos, were a kind gift from O. Brison. All
cells were treated with 0.5 mg/ml doxorubicin or with 10 mM
Nutlin 3a for 24 h before RNA or protein extractions.
Quantitative RT–PCR
Total RNA was extracted using NucleoSpin RNA II (Ma-
cherey-Nagel) and reverse transcribed with Superscript III First-
Strand Synthesis Supermix (Invitrogen). Real-time quantitative
PCR was performed on an ABi Prism 7500 system using Power
SYBR Green master mix (ABi). Primers for detecting cDNA
sequence of mouse, human or rat p21, p130, Ncoa1, Klhl26 and
controls Rplp0 and PPIA were designed with Primer3 Input
(version 0.4.0). All mRNA expression levels were normalized to
both Rplp0 and PPIA. Primer sequences are listed in Table S5.
Western blots
Protein detection by immunoblotting was performed using
antibodies raised against p53 (CM5, Novocastra), p130 (C20,
Santa-Cruz), GAPDH (mAb 374, Millipore), Ncoa1 (M-341,
Santa Cruz), Klhl26 (C-14, Santa Cruz) and actin (A2066, Sigma).
Chemiluminescence revelation of western blots was achieved with
the SuperSignal substrates (Perbio, France).
In silico search for putative p53 response elements
We first used a positional frequency matrix (PFM) for p53
response elements [19], modified to take varying spacer lengths (0–
13 bp) into account (Figure S2), with the Consite software (http://
asp.ii.uib.no:8090/cgi-bin/CONSITE/consite) to calculate the
average score of p53 REs from known p53 target genes [17]: a
mean value (M) of 11.7 was found, with a standard deviation (SD)
of 1.2. We then used the same PFM to search for putative p53 REs
at the Rbl2, Ncoa1 and Klhl26 loci, and considered motifs with a
CNWGNNN(0–13)NNNCNWR core sequence and a Consite
score .10.5 as putative REs. Putative REs were plotted against
the map as lollipops and included in Tables S1, S2, S3, S4, S5, S6,
S7, S8, with greytones according to their score: white for scores
between 10.5 and 12.9 (M+/2SD), black for scores .15.3 (M+3
SD), and grey for scores between 12.9 and 15.3.
Figure 5. Comparative Consite analysis of Rbl2 sequences from
11 mammalian species. The sequences for the first 2.5 kb
downstream of the Rbl2 transcription start site (mouse, rat, dog, cattle,
rhesus monkey, gibbon, chimp, human) or translation start site (rabbit,
horse, elephant) were analyzed using Consite as before. Results are
represented as in Figure 1D.
doi:10.1371/journal.pgen.1002731.g005
Figure 6. Comparative Consite analyses of Ncoa1 and Klhl26 sequences from 7 mammalian species. The 4 kb of DNA sequences upstream
of the Ncoa1 transcription start site (left), or the 2 kb surrounding the Klhl26 transcription start site (right), were analyzed in 7 mammalian species
using Consite as before. Results are represented as in Figure 1D. Shorter lines, or dashed lines within brackets, indicate incomplete sequences.
doi:10.1371/journal.pgen.1002731.g006
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Basic local alignment tool (BLAST) searches were performed
using MouseBLAST (running WU-BLAST 2.0) from the Mouse
Genome Informatics website (www.informatics.jax.org), with the
BLASTN and Repeatmasker/rodents options. BAC clones
identified as containing significant homology to clusters were then
analyzed with Map Viewer from the National Center for
Biotechnology Information (NCBI) website (www.ncbi.nlm.nih.
gov/projects/mapview) to check if they contained genes. The
DNA sequences of BACs with genes were retrieved using the
NCBI clone registry and p53 half-site clusters were precisely
mapped relative to genes by using Ensembl mouse gene
annotations (www.ensembl.org/Mus_musculus/Info/Index).
Sequence analysis with mreps
We used mreps (http://bioinfo.lifl.fr/mreps/mreps.php) with
default settings, and searched for repeats with error rates ,0.2.
This revealed fuzzy tandem repeats for the 3 murine clusters.
When homologous human sequences were analyzed with the same
criteria, mreps failed to detect fuzzy repeats.
Luciferase expression assays
To construct the p53 RE reporter plasmids, we cloned full
promoters upstream of the firefly luciferase gene in a pGL3-basic
vector (Promega), and partial promoter or intronic sequences
upstream of a SV40-minimal promoter before the firefly luciferase
gene (in a vector called below pGL3-PromMini or EmRep).
Primers used to construct the reporter plasmids are listed in Table
S6. For each experiment, 10
6 exponentially growing p53
2/2 cells
were nucleofected (using the Lonza MEF2 nucleofector kit) by
3 mg of a p53 RE-firefly luciferase reporter plasmid; 3 mg of the
same reporter plasmid and 3 mg of a WT p53 expression plasmid;
or 3 mg of the same reporter plasmid and 3 mg of a p53
R270H
expression plasmid. For all points, data were normalized by adding
30 ng of renilla luciferase expression plasmid (pGL4.73, Promega).
Nucleofected cells were allowed to grow for 24 h, then trypsinized,
resuspended in 75 ml culture medium and transferred into a well of
an optical 96 well plate (Nunc). The dual-glo luciferase assay
system (Promega) was used according to the manufacturer’s
protocol to lyse the cells and read firefly and renilla luciferase
signals.
Chromatin immunoprecipitation
ChIP analysis was performed essentially as described [40]. In
brief, adherent p53
+/+ and p53
2/2 MEFs were treated with
doxorubicin (0.5 mg/ml) for 24 h. Cellular proteins from 10
8 cells
were crosslinked to chromatin with 1% formaldehyde for 10 min
at 25uC. p53-DNA complexes were immunoprecipitated from
total extracts by using 50 mg of rabbit polyclonal p53 antibody
(FL-393, Santacruz) and 500 mg of sonicated chromatin. Rabbit
IgG (Abcam) was used for control precipitation. Quantitative PCR
was performed on an Applied Biosystems 7500 instrument using
Power SYBR Green master mix (ABi). Primer sequences are
reported in Table S7.
Whole-body gamma-irradiation
Age-matched mice were irradiated at 6–8 weeks with a Cs
gamma-irradiator with 2.9 Gy/min at a dose of 10 Gy. Mice
were sacrificed 3 h later and organs were recovered, then total
RNA was extracted using Trizol (Invitrogen) and quantified as
before. Experiments were performed according to IACUC
regulations.
Supporting Information
Figure S1 Whole-body irradiation leads to Rbl2/p130 induction
in tissues of wild-type but not p53
2/2 mice. Age-matched 6–8
weeks old wild-type (WT) and p53
2/2 (KO) mice were left
untreated or submitted to 10 Gy whole-body gamma-irradiation
(irr.), before RNA extraction and real-time PCR quantification.
Results are from 4 WT and 4 p53
2/2 mice.
(TIF)
Figure S2 Matrices used for the search of candidate p53
Response Elements. (A) The positional frequency matrix used to
search for candidate p53 Response Elements is shown. For each of
the 20 positions, the percentage of occurrence for nucleotides A,
C, G, and T is represented. The matrix comes from experimental
data by Smeenk et al. [19]. (B) Matrices with varying spacer length
used in our Consite analyses. The spacers of varying length were
derived from the matrix in (A) by adding 0–13 equiprobable values
after the first half-site. Five out of the 14 matrices used are shown
as examples (numbers in parentheses indicate spacer length).
(TIF)
Figure S3 The cluster of p53REs in murine Rbl2 mediates a
p53-dependent regulation. Luciferase was measured in p53
2/2
MEFs transfected with an empty reporter plasmid (EmRep, a
plasmid with a SV40-minimal promoter before the firefly
luciferase gene), or with the same plasmid and an expression
vector for WT p53 (EmRep+p53WT) or mutant p53 (Em-
Rep+p53R270H). Likewise, ClusRep, a reporter plasmid in which
a 163 bp-long fragment encompassing the Rbl2 cluster of p53REs
was cloned upstream the SV40-minimal promoter, was transfected
into p53
2/2 MEFs alone (ClusRep), or with expression vectors for
WT (ClusRep+p53WT) or mutant p53 (ClusRep+p53R270H),
and luciferase activity was measured. Results, from 2 independent
experiments, were normalized to control renilla luciferase, then a
value of 1 was assigned to luciferase in cells transfected with
reporter plasmids alone.
(TIF)
Figure S4 Detailed results of the sequence analysis of the murine
Rbl2 cluster with mreps. Positions are relative to the transcription
start site. Period designates the length of a repeat, exponent the
number of its occurrences, size the total length, and error rate the
relative weight of mismatches. Alignments with error rates ,0.2
are shown.
(TIF)
Figure S5 A p53-dependent increase in Ncoa1 and Klhl26
protein levels. p53
2/2 and WT MEFs were left untreated or
treated with doxorubicin (Dox), then protein extracts were
immunoblotted with antibodies to Ncoa1, Klhl26, p53 and actin.
A clear p53-dependent induction of Ncoa1 is visible. Endogenous
Klhl26 levels were barely visible, but were detected more easily in
WT stressed cells.
(TIF)
Figure S6 Detailed results of the sequence analysis of the murine
Ncoa1 cluster with mreps. Positions are relative to the transcription
start site. Results are presented as in Figure S4.
(TIF)
Figure S7 Detailed results of the sequence analysis of the murine
Klhl26 cluster with mreps. Positions are relative to the transcription
start site. Results are presented as in Figure S4.
(TIF)
Figure S8 Sequences of clustered putative p53 half-sites from 11
mammalian Rbl2 loci. Clustered putative p53 binding half-sites
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PLoS Genetics | www.plosgenetics.org 9 June 2012 | Volume 8 | Issue 6 | e1002731(containing 0–3 mismatches with the consensus) were searched for
in Rbl2 sequences from 11 mammalian species and plotted as
follows: putative half-sites are in bold (with matches in capital
letters and mismatches in lowercase); perfect half-sites are boxed;
half-sites with a single mismatch are underlined; half-sites with a
deletion or insertion in the CWWG core are within parentheses.
Numbers are relative to the transcription start sites (mouse, rat,
dog, cattle, rhesus monkey, gibbon, chimp, human) or the
translation start sites (rabbit, horse, elephant).
(TIF)
Figure S9 Sequences of clustered putative p53 half-sites from 7
mammalian Klhl26 loci. Clustered putative p53 binding half-sites
in Klhl26 sequences from 7 mammalian species were searched for
and plotted as in Figure S8. Numbers are relative to the
transcription start sites.
(TIF)
Table S1 Consite analysis of Murine and Human Rbl2 loci.
Candidate p53 REs are listed, with spacer sequences in lowercase.
Half-sites from candidate p53 REs mapping in the cluster region
are in bold type, those from p53 REs outside of the cluster are in
italics (see also Figure 1). Gtn: Greytone assigned according to
score, as for lollipops in Figure 1.
(DOC)
Table S2 Consite analysis of clustered putative p53 half-sites
upstream murine Ncoa1. Candidate p53 REs are listed as in Table
S1.
(DOC)
Table S3 Sequences of the 128 p53 RE motifs used in whole
genome BLAST searches. The 128 motifs are likely to be the most
frequent p53 response elements, because they are composed of
nucleotides present, at each position, in at least 34% of p53-bound
REs (according to the PFM, see Figure S2). For each p53 RE, a
nucleotide that differs from that at the same position in the first
motif is highlighted in red.
(DOC)
Table S4 Consite analysis of clustered putative p53 half-sites in
murine Klhl26. Candidate p53 REs are listed as in Table S1.
(DOC)
Table S5 Primers used in quantitative RT-PCR experiments.
(DOC)
Table S6 Primers and methods for the construction of luciferase
reporter plasmids.
(DOC)
Table S7 Primers used in ChIP experiments.
(DOC)
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